Skip to main content
OpenTrials

Clinical trial condition

Ectodermal Dysplasia

Explore clinical trials studying Ectodermal Dysplasia. Study availability and eligibility vary by location and protocol.

34 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Ectodermal Dysplasia trial results

Completed

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita

NCT04520750

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Minnesota Clinical Study Center Fridley, Minnesota, United States
  • University of Utah Murray, Utah, United States
View Trial Details
Completed

Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita

NCT03920228

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • International Dermatology Research Miami, Florida, United States
View Trial Details
Completed

Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia

NCT02099552

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hôpital Necker-Enfants Malades Paris, France
View Trial Details
Completed

Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

NCT01775462

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hôpital Necker-Enfants Malades Paris, France
View Trial Details

Related conditions